Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

NAUT Nautilus Biotechnology Inc

2,80

0,13 (4,87%)

10 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Nautilus Biotechnology Charts.

Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Nautilus Biotechnology Charts.

News Nautilus Biotechnology Inc

Nautilus Biotechnology Reports First Quarter 2024 Financial Results
Dienstag 30 April 2024 (1 Woche vor) • GlobeNewswire Inc.

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
Donnerstag 11 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Mittwoch 28 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 28 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Mittwoch 28 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Nautilus Biotechnology Inc News-Artikel

JP Morgan Chase

Energy Select Sector SPDR

Deutsche Telekom (QX)

Deutsche Telekom

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen